- Global Pharma News & Resources

NetNoggin® announces the release of NetNog: #genesis® Cystic Fibrosis Patient and Caregiver Journeys

FREDERICK, Md., Feb. 26, 2019 /PRNewswire/ -- In honor of Rare Disease Day on Thursday, NetNoggin®, a premier market research agency that specializes in pharmaceutical marketing, has announced the release of its newest offering, NetNog: #genesis® Cystic Fibrosis Patient and Caregiver Journeys. Learn more:

"Growing up, I had a neighbor who passed away from Cystic Fibrosis, which had a profound effect on me. During college, I volunteered to assist parents by performing Chest Physical Therapy on children with Cystic Fibrosis," said Diana Conger, Chief Executive Officer at NetNoggin®.  "With this in mind, and advances in research, we chose Cystic Fibrosis as our first NetNog: #genesis® report and first syndicated patient/caregiver journeys report."

NetNog: #genesis® Cystic Fibrosis Patient and Caregiver Journeys offer pharmaceutical companies a first-time advantage by starting their commercialization strategy already understanding the five perspectives of the Cystic Fibrosis journey, captured from patient and caregiver voices. The journeys are:

  1. Clinical patient pathway showing the patient journey from symptom onset to end-of-life
  2. Patient journey illustrating pathways and experiences beyond the clinical setting
  3. Patient emotional journey capturing patient-expressed emotions
  4. Caregiver journey describing how loved-ones are affected by this disease
  5. Caregiver emotional journey capturing caregiver-expressed emotions

NetNog: #genesis® Cystic Fibrosis Patient and Caregiver Journeys is part of the comprehensive NetNog: #genesis® Cystic Fibrosis research report, which includes secondary research to understand the marketspace; netnographic findings to understand patients'/caregivers' perspectives; as well as insights, recommendations, and gaps in the market.

Visit to learn more about NetNog: #genesis® Cystic Fibrosis Patient and Caregiver Journeys.

About NetNoggin®
NetNoggin®, a subsidiary of Conger Consulting, LLC, is a premier market research agency that specializes in pharmaceutical marketing. NetNoggin® utilizes netnography to analyze and provide context to Big Data. By leveraging 30+ years of experience, our proprietary process derives strategic consulting insights from Big Data to inform Foundational Marketing Tools (FMTs), strategies, and tactics. NetNoggin® has expertise in market research; commercial, market, and clinical development; and communications to provide reliable research, presentations, and workshops. NetNoggin® was established in 2011. The founder, Diana Conger, has been involved in bringing over 20 pharmaceutical products to market and has in-depth knowledge of over 50 disease-states.

NetNoggin® Media Relations
If you would like more information about this topic, please contact Megan Newcomer.

View original content to download multimedia:

SOURCE NetNoggin

Editor Details

Last Updated: 26-Feb-2019